)
ReLabLink: A marketplace for used laboratory equipment and consumables
There's a second-hand market for everything from sailboats to old vases. So why not for laboratory equipment? Lab lead Emmanuelle Benard saw the need and created a new service.
Veronika Barrabés and Professor Kjetil Taskén join the board of ShareLab
Published: 18 September 2026
Text: Anne-Marie Korseberg Stokke
)
The biotechnology incubator ShareLab at Oslo Science Park is experiencing strong growth and is now strengthening its board with two members who bring extensive experience from the health industry, research, and biotech.
Veronika Barrabés is Managing Director of Novartis Norway and has over 20 years of experience in the pharmaceutical industry. She also sits on the board of LMI (the Norwegian Association of the Pharmaceutical Industry) and is a former member of the state-appointed HelseOmsorg21 Council.
Physician and researcher Kjetil Taskén is head of the Institute for Cancer Research at Oslo University Hospital and professor of medicine at the University of Oslo. He has extensive experience as a research director, including as director of the Centre for Molecular Medicine and the Biotechnology Centre of Oslo, and has held key roles in European research infrastructure. Taskén has also been active in the business world as co-founder and board member of several biotechnology companies, and has contributed to the commercialization of research in collaboration with Inven2.
"We are incredibly pleased to welcome Veronika and Kjetil onto the board. They represent two sides of the same coin — commercial weight from the pharmaceutical industry and deep scientific insight — which together cover exactly the range ShareLab works within every single day. This significantly strengthens us in the work of helping more research-based companies through the journey from lab to market," says Esben A. Nilssen, Managing Partner at ShareLab.
The new board consists of Barrabés and Taskén in addition to Chairman Bjørn Erik Reinseth, CEO of Oslo Science Park:
"Since Oslo Science Park established ShareLab in 2018, commercialization of biotechnological research has been central. We are very pleased to strengthen the board with Veronika Barrabés and Kjetil Taskén, who bring their perspectives from both industry and the application of research into ShareLab," says Reinseth.
ShareLab
ShareLab is Scandinavia's leading biotech incubator for academia, startups, and industry. They offer office spaces, fully equipped laboratories, lab management, a professional and commercial network, and mentoring.
Related articles
)
Fenris Bio: Aiming to challenge current Crohn’s Disease treatment
Fenris Bio was founded on the basis of an idea without experimental data, but with investors willing to take the risk. Now, the ShareLab company is working to test the first candidates for a new biological medicine for Crohn’s disease.
)
Health Innovation: “Encouraging to see more companies emerging from OUS”
As almost the closest neighbor to Oslo University Hospital (OUS), it is a short walk for researchers and clinicians to the innovation ecosystem at Forskningsparken. In the ShareLab incubator, there is now a long list of OUS-based companies on the membership roster.
)
Maria Vistnes at Klyv Therapeutics: From lab coat to the executive chair
After many years as a cardiologist and researcher, Maria Vistnes has traded hospital corridors and academia for a day-to-day life as a founder in her own biotechnology company, Klyv Therapeutics. The driving force is not a desire to leave the medical profession, but a conviction that the most effective way to help patients is to develop a new treatment.
)
)
Cellmover: Norwegian biotechnology success paves the way for new cancer treatment
Cellmover is now making great strides in developing next-generation cancer therapies. The company has recently secured funding through the Eurostars program, and CSO Miriam Aarsund Larsen has been named one of Norway's 50 leading women in technology. How did she transition from researcher to leader, and what is driving Cellmover forward?